NCT05077865View on ClinicalTrials.gov

Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

August 1, 2021

Study Completion Date

August 1, 2021

Conditions
Hashimoto Disease
Interventions
DRUG

MYMD-1

150 mg capsule

DRUG

Placebo

Matching in appearance to MyMD-1 150mg capsule

Trial Locations (1)

33765

Clinical Research of West Florida, Inc, Clearwater

All Listed Sponsors
lead

TNF Pharmaceuticals, Inc.

INDUSTRY